Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Electronic Theses and Dissertations bannerUCLA

Correlates of Injectable Contraceptive Discontinuation following HIV Seroconversion in an HIV Prevention Trial

  • Author(s): Caplan, Margaret Rae
  • Advisor(s): Elashoff, Robert M
  • et al.
Abstract

Background: Injectable contraception (IC) is the most common form of highly effective contraception currently used in sub-Saharan Africa; however, its use has not been well described in HIV-infected women in the post-seroconversion period. This analysis aimed to examine factors associated with IC discontinuation following HIV seroconversion in an HIV prevention trial. Methods: Following HIV acquisition in a prevention trial, 255 African women were enrolled in a longitudinal observational study (MTN-015). IC use was evaluated at MTN-015 entry and at 3, 12, and 24 months. Correlates of IC discontinuation were examined by Cox proportional hazard modeling.Results: Of baseline IC users, 34% (61/182) of women with follow-up data discontinued use of IC without a non-barrier substitution. Having at least one child (adjusted HR 0.38, p= 0.03) and earning personal income (adjusted HR 0.58, p= 0.05) were associated with lower rates of IC discontinuation. Conclusion: IC discontinuation was common post-seroconversion in HIV-infected African women despite onsite contraceptive services. Many women with recently acquired HIV face complex decision-making regarding family planning.

Main Content
Current View